Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/MEDICO stock hub

NSE/MEDICO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/MEDICOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.4B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/MEDICO

In the news

Latest news · NSE/MEDICO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E29.7

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC13.1

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/MEDICO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

174

Groups with data

Currency

INR

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	213
Employees Change	20%
Employees Change Percent	10.36
Enterprise value	INR 3.6B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE630Y01024
Last refreshed	2026-05-10
Market cap	INR 3.4B
Price	INR 41.6
Price currency	INR
Rev Per Employee	8,961,164.32x
Sector	Healthcare
Sic	2834
Symbol	nse/MEDICO
Website	https://medicoremedies.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.37%
EV Earnings	30.62x
EV/EBIT	26.34x
EV/EBITDA	21.46x
EV/Sales	1.86x
P/B ratio	5.15x
P/E ratio	29.69x
P/S ratio	1.8x
PE Ratio10 Y	39.26x
PE Ratio3 Y	56.75x
PE Ratio5 Y	49.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.06%
EBITDA Margin	8.45%
Gross margin	26.04%
Gross Profit	INR 497.1M
Gross Profit Growth	29.88%
Gross Profit Growth Q	34.6%
Gross Profit Growth3 Y	11.39%
Gross Profit Growth5 Y	12.21%
Net Income	INR 116M
Net Income Growth	31.04%
Net Income Growth Q	9.64%
Net Income Growth Quarters	5%
Net Income Growth Years	7%
Net Income Growth3 Y	15.57%
Net Income Growth5 Y	35.62%
Pretax Margin	8.09%
Profit Margin	6.08%
Profit Per Employee	INR 544,573
Profitable Years	13
Roa5y	5.23
Roe5y	15.01
ROIC	13.05
Roic5y	10.22

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-22.46%
Cagr3y	-21.48%
EPS Growth	32.1
EPS Growth Q	9.38
EPS Growth Quarters	5
EPS Growth Years	7
EPS Growth3 Y	15.58
EPS Growth5 Y	35.59
Revenue Growth	26.44x
Revenue Growth Q	48.6x
Revenue Growth Quarters	3x
Revenue Growth Years	3x
Revenue Growth3 Y	9.67x
Revenue Growth5 Y	10.68x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 17.6M
Debt	INR 125.3M
Debt EBITDA	INR 0.76
Debt Equity	INR 0.19
Equity	INR 668.6M
Interest Coverage	12.34
Net Cash	INR -107.6M
Net Cash By Market Cap	INR -3.13
Net Debt EBITDA	INR 0.67
Net Debt Equity	INR 0.16
Tangible Book Value	INR 668.1M
Tangible Book Value Per Share	INR 8.06
WACC	7.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-22.45%
200-day SMA	45.09
3Y total return	-51.6%
50-day SMA	40.42
50-day SMA vs 200-day SMA	50under200
All Time High	100.7
All Time High Change	-58.69%
All Time High Date	2023-05-31
All Time Low	16.52
All Time Low Change	151.82%
All Time Low Date	2022-08-10
ATR	2.09
Beta	0.56
Ch YTD	-17.79
High	42.6
High52	58.99
High52 Date	2025-05-29
High52ch	-29.48%
Low	41.16
Low52	30.22
Low52 Date	2026-03-30
Low52ch	37.66%
Ma50ch	2.91%
Price vs 200-day SMA	-7.74%
RSI	55.37
RSI Monthly	46.56
RSI Weekly	45.53
Sharpe ratio	-0.34x
Sortino ratio	-0.4
Total Return	0.8%
Tr YTD	-17.79
Tr1m	5.16%
Tr1w	-1.86%
Tr3m	-12.99%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 134.8M
Operating Income Growth	35.08
Operating Income Growth Q	50.78
Operating Income Growth3 Y	29.9
Operating Income Growth5 Y	32.97
Operating margin	7.06

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,044,610%
Shares Insiders	74.96%
Shares Institutions	1.2%
Shares Qo Q	-0.94%
Shares Yo Y	-0.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	178,882.8x
Bv Per Share	8.07
Ch1m	5.16
Ch1w	-1.86
Ch1y	-22.45
Ch3m	-12.99
Ch3y	-51.6
Ch6m	-16.52
Change	-1.02%
Change From Open	-2.35
Close	42.03
Days Gap	1.36
Depreciation Amortization	26,474,250
Dollar Volume	4,634,198.4
Earnings Date	2026-05-30
EBIT	INR 134.8M
EBITDA	INR 161.3M
EPS	INR 1.4
F Score	2
Fiscal Year End	March
Founded	1,994
Graham Number	15.95641
Graham Upside	-61.64
Income Tax	INR 38.4M
Is Primary Listing	0
Last Earnings Date	2026-02-12
Last Report Date	2025-12-31
Last Split Date	2023-03-16
Last Split Type	Forward
Lynch Fair Value	INR 35.03
Lynch Upside	-15.8
Ma150	46.71
Ma150ch	-10.95%
Ma20	40.82
Ma20ch	1.91%
Next Earnings Date	2026-05-30
Open	42.6
Position In Range	30.56
Price Date	2026-05-08
Price EBITDA	INR 21.35
Ptbv Ratio	5.15
Relative Volume	0.64x
Revenue	1,908,728,000x
Tax By Revenue	2.01x
Tax Rate	24.87%
Tr6m	-16.52%
Volume	111,399

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/MEDICO pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/MEDICO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/MEDICO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.2%

Share of float held by funds and institutions

Insider ownership

+75.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.8%

Negative means the company is buying back shares.

Technical

NSE/MEDICO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.4

Neutral momentum band

Price vs 200-day MA

-7.7%

50/200-day relationship not available

Beta (5Y)

0.56

Less volatile than the market

Sharpe ratio

-0.34

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/MEDICO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/MEDICO stock rating?

nse/MEDICO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/MEDICO analysis?

The full report lives at /stocks/nse/MEDICO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/MEDICO?

The latest report frames nse/MEDICO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/MEDICO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.